参考文献/References:
[1]Clyman RI.Patent ductus alteriosus in the preterm infant[M].9th ed.Gleason CA,Devaskar SU.Avery'S Diseases of the Newborn.Philadel-phia:Elsevier Saunders,2012:751-761.
[2]郑军,王晓鹏,刘鸽.早产儿动脉导管未闭防治的新观点[J].中华实用儿科临床杂志,2018,33(2):89-92.
[3]Kluckow M.Oral Ibuprofen and the Patent Ductus Arteriosus:A New Approach to an Old Problem[J]. Jornal de Pediatria,2013,89(1):4-5.
[4]Weindling M.Avery's Diseases of the Newborn(Ninth Edition)[M].9th ed.Philadelphia,Elsevier,2012:751-761.
[5]StollL BJ,Hansen NI,BellE F,et al.Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network[J].Pediatrics,2010,126(3):443-456.
[6]Kim SY,Shin SH,Kim HS,et al.Pulmonary arterial hypertension after ibuprofen treatment for patent ductus arteriosus in very low birth weight infants[J].The Journal of Pediatrics,2016,179:49-53,e1.
[7]Wardle AJ,Osman A,Tulloh R,et al.Patent ductus arteriosus:an analysis of management[J].Cardiology in the Young,2014,24(5):941-943.
[8]Saldeno YP,Favareto V,Mirpuri J.Prolonged persistent patent ductus arteriosus:potential perdurable anomalies in premature infants[J].J Perinatol,2012,32(12):953-958.
[9]McQuade CN,Mizus M,Wald JW,et al.Brain-Type Natriuretic Peptide and Amino-Terminal Pro-Brain-Type Natriuretic Peptide Discharge Thresholds for Acute Decompensated Heart Failure:A Systematic Review[J].Ann Intern Med,2017,166(3):180-190.
[10]陈影芳,吴坚洪,梁宇亨,等.肌钙蛋白Ⅰ、肌红蛋白、N-末端 B 型尿钠肽前体和肌酸激酶同工酶在心肌梗死早期诊断中的应用[J].包头医学院学报,2015,31(11):82-83.
[11]李雷花,孙俊红.血清 HCY、CysC、NT-proBNP、D-dimer 联合检测在慢性心力衰竭诊断及预后评估中的价值[J].实验和检验医学,2018,36(3):427-433.
相似文献/References:
[1]张艳妮,李世玲,邓 春.动脉导管未闭与支气管肺发育不良发生风险相关性的Meta分析[J].医学信息,2023,36(18):33.[doi:10.3969/j.issn.1006-1959.2023.18.006]
ZHANG Yan-ni,LI Shi-ling,DENG Chun.Meta-analysis of the Correlation Between Patent Ductus Arteriosus and the Risk of Bronchopulmonary Dysplasia[J].Journal of Medical Information,2023,36(12):33.[doi:10.3969/j.issn.1006-1959.2023.18.006]